Dimer Health vs Verily
Two clinical programmes wrapped in software, sold to different buyers for different windows. Dimer runs clinician led transitional care in the days after discharge, which is when readmission risk peaks and support is thinnest, and it is a bounded episode with a measurable endpoint. Verily runs chronic condition management and research programmes for plans, employers and pharmacy benefit managers, with a credible certification set and a better designed privacy structure than most consumer facing arrangements here. If your exposure is readmission penalties, Dimer is aimed at that specific window. If it is a chronic population managed across years, Verily is built for the longer horizon. Neither publishes engagement adjusted outcomes, which is what would show either programme worked rather than selected.
- Clinician led transitional care concentrates on the days after discharge, when readmission risk is highest and support is thinnest.
- A bounded episode with a measurable endpoint makes the programme's effect easier to attribute than ongoing monitoring.
- For an organisation whose exposure is readmission penalties, the intervention window is the one that matters.
- It runs chronic condition management and research programmes for plans, employers and pharmacy benefit managers with a credible certification set.
- The health privacy structure is better designed than most consumer facing arrangements in this index.
- Agents triage and escalate members to a clinical team, with commitments published in language a member can read.
Side by Side
| Axis | D Dimer Health |
V Verily |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Remote Monitoring & Chronic Care page.
The buyers differ, one selling to health systems carrying readmission exposure and the other to plans, employers and pharmacy benefit managers, so a like for like cost comparison does not exist. Neither publishes engagement adjusted outcomes, which is the figure that separates a programme that worked from one that recruited the already motivated. Verily names its products and agents but not the technology beneath them and publishes no governance framework. Dimer publishes little on security or retention.